Skip to content
Recall Observatory FDA recall evidence

Drug product

Amlodipine Besylate Tablets, USP, 5 mg, packaged in a) 90-count bottles (NDC 0378-5209-77) and b) 500-count bottles (NDC 0378-5209-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

D-66403-005

September 13, 2013

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 66403
Status
Terminated
Classification
Class II
Quantity
167,866 bottles
Official record key
drug-enforcement:D-66403-005

Official wording

Reason: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Code information: Lot s: a) 3036490, 3036491, 3036492, 3039874; b) 3036493, 3036494, 3039872, 3039873, 3041476, 3041477, 3044555, 3044683

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations